@immunext.com
ImmuNext is a develops compounds on the cutting edge of immunotherapy for cancer.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
ImmuNext is a leading brand in the field of immunotherapy for autoimmune diseases and cancer. With a focus on derisking immunomodulatory targets, ImmuNext develops cutting-edge compounds that pave the way for innovative treatments. The brand has established valuable partnerships with renowned companies such as Janssen, Roche, Sanofi, Eli Lilly, and Curis.
ImmuNext currently has clinical stage programs centered around CD40L and VISTA, which is a checkpoint regulator. Additionally, their pre-clinical programs are dedicated to developing antibodies that target novel immuno-metabolic proteins. This commitment to research and development positions ImmuNext at the forefront of immunotherapy advancements.
The brand boasts a highly skilled team that merges expertise in immunology, preclinical development, and business development. Located on the Dartmouth Hitchcock Medical Center campus in Lebanon, NH, ImmuNext embraces collaboration with Dartmouth Health, the Geisel School of Medicine, and Thayer School of Engineering, allowing for enriching academic and translational research opportunities. With its strategic location in Lebanon, NH, ImmuNext benefits from both the intellectual stimulation of Dartmouth College and the picturesque charm of rural New England.
Choose ImmuNext to unlock the potential of immunotherapy in the fight against autoimmune diseases and cancer
Company Type
Privately Held
Company Size
11-50
Year Founded
2011
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories